National surveillance for meningococcal disease in Japan, 1999-2014

Munehisa Fukusumi1, Hajime Kamiya2, Hideyuki Takahashi3

  • 1Field Epidemiology Training Program (FETP), National Institute of Infectious Diseases, Tokyo, Japan; Department of Epidemiology for Infectious Diseases, Osaka University, Graduate School of Medicine, Japan.

Vaccine
|June 14, 2016
PubMed

Insights

Japanese meningococcal disease (IMD) remains rare, with serogroup Y dominating cases. Enhanced surveillance is crucial for accurate epidemiology and vaccine recommendations.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health Surveillance

Background:

  • Invasive meningococcal disease (IMD) reporting in Japan was amended in April 2013 to include bacteremia.
  • Prior to April 2013, only meningococcal meningitis cases were reported.

Purpose of the Study:

  • To summarize the epidemiology and serogroup distribution of IMD in Japan.
  • To assess the impact of amended reporting requirements on IMD case detection.

Main Methods:

  • Analysis of national surveillance data from April 1999 to December 2014.
  • Inclusion of both meningococcal meningitis and bacteremia cases from April 2013 onwards.

Main Results:

  • From April 1999 to March 2013, 178 meningitis cases were reported. From April 2013 to December 2014, 59 IMD cases (meningitis and bacteremia) were reported.
  • The median age of IMD cases was 56 years, with 66% being male. Only 3% of cases were under 5 years old.
  • Serogroup Y was the most prevalent (42%), followed by C (12%), B (7%), and W (3%). The annual incidence in 2014 was 0.028 per 100,000, with a case fatality rate of 19%.

Conclusions:

  • Despite increased reporting, IMD incidence in Japan remains low, potentially due to underreporting.
  • Serogroup Y is the dominant cause of IMD in Japan.
  • Improvements in surveillance are needed to accurately capture IMD epidemiology and serogroup distribution for effective vaccination strategies.

Related Concept Videos

Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...